Oscar Health, Inc. (OSCR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on September 4, 2024. The filing serves as a Regulation FD disclosure to announce the Company's scheduled participation in three major healthcare industry conferences in September 2024.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural announcement regarding upcoming investor presentations rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing confirms that the Company will reaffirm the updated full-year 2024 guidance previously issued in its second-quarter 2024 financial results press release dated August 7, 2024.
Guidance, Outlook, and Risks
- Conference Schedule: The Company will present at the Wells Fargo Healthcare Conference (Sept 4), Morgan Stanley 22nd Annual Global Healthcare Conference (Sept 5), and Baird 2024 Global Healthcare Conference (Sept 11).
- Guidance Reaffirmation: Management intends to reiterate the full-year 2024 guidance provided in the Q2 2024 earnings release.
- Access: Presentations will be available via virtual webcast on the Company's investor relations website.
- Risks: The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially due to risks outlined in the Company's 2023 Form 10-K and Q2 2024 Form 10-Q.
Investor Verification Checklist
- Verify the specific details of the updated full-year 2024 guidance in the August 7, 2024 press release.
- Review the Q2 2024 Form 10-Q for the most recent financial performance data.
- Confirm the webcast access instructions on the investor relations website (ir.hioscar.com) prior to the conference dates.
- Monitor the "Risk Factors" section of the 2023 Form 10-K for potential impacts on the reaffirmed guidance.